• Dr. Carlo M. Contreras completed his surgical oncology training at the M.D. Anderson Cancer Center in Houston, TX. There, his focus was on the most effective surgical approaches to hepatobiliary and pancreatic malignancies. As a member of the UAB Surgical Oncology faculty he cares for patients with a wide variety of malignancies including skin, soft tissue, and gastrointestinal. He promotes a patient-centered approach, and feels that effective communication is paramount in the multidisciplinary care of his patients. Dr. Contreras is pleased to offer a broad range of oncologic therapies, including minimally invasive and robotic approaches. He is the Director of the UAB Surgical Oncology Tissue Bank, and participates in clinical trials.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Pathological complete response after neoadjuvant pembrolizumab and radiation 2019
    2019 Gastrointestinal Stromal Tumors of the Stomach and Esophagus 2019
    2019 Cutaneous melanoma, version 2.2019 2019
    2019 Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies 2019
    2019 Healthcare disparities in outcomes of patients with resectable pancreatic cancer 2019
    2018 Timed Stair-Climbing as a Surrogate Marker for Sarcopenia Measurements in Predicting Surgical Outcomes. 2018
    2018 Merkel Cell Carcinoma, Version 1.2018 2018
    2018 PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids 2018
    2018 Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases 2018
    2017 Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base 2017
    2017 Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity 2017
    2017 Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target 2017
    2017 Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity 2017
    2016 Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions 2016
    2016 Comparative Proteomic Analysis of Whole-Gut Lavage Fluid and Pancreatic Juice Reveals a Less Invasive Method of Sampling Pancreatic Secretions. 2016
    2016 Timed Stair Climbing is the Single Strongest Predictor of Perioperative Complications in Patients Undergoing Abdominal Surgery 2016
    2011 Radiographic and clinical factors associated with improved outcomes in advanced cancer patients with bowel obstruction 2011
    2011 Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: A study of 112 patients with limited lung metastatic disease 2011
    2011 Adjuvant trials for pancreatic cancer: where are we going and what is needed? 2011
    2010 Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases 2010
    2010 Staging systems: Is there a surgical staging and a medical one? A surgeon's perspective 2010
    2010 Metastasectomy of combined liver and lung colorectal cancer metastases 2010
    2009 Staging laparoscopy enhances the detection of occult metastases in patients with pancreatic adenocarcinoma 2009
    2007 1-41 Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast Cancer 2007
    1999 In vitro recoating of reovirus cores with baculovirus-expressed outer- capsid proteins μ1 and σ3 1999
    1998 Binding site for S-adenosyl-L-methionine in a central region of mammalian reovirus λ2 protein. Evidence for activities in mRNA cap methylation 1998


    Year Title Altmetric
    2012 Hepatic steatosis, steatohepatitis, and chemotherapy-related liver injury.  999-1005. 2012
    2011 Multidisciplinary care of the hepatocellular carcinoma patient.  81-88. 2011
    2011 Neuroendocrine cancers.  301-324. 2011

    Education And Training

  • University of Wisconsin Hospital & Clinics, Residency 2008
  • MD Anderson Cancer Center, Postdoctoral Fellowship 2010
  • Full Name

  • Carlo Contreras